Global Gene Therapy for Ovarian Cancer Market Research Report 2023

Report ID: 1988905 | Published Date: Jan 2025 | No. of Page: 64 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Intravenous
        1.2.3 Intratumoral
        1.2.4 Intraperitoneal
    1.3 Market by Application
        1.3.1 Global Gene Therapy for Ovarian Cancer Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Ovarian Cancer (Unspecified)
        1.3.3 Recurrent Ovarian Epithelial Cancer
        1.3.4 Platinum-Resistant Ovarian Cancer
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Gene Therapy for Ovarian Cancer Market Perspective (2017-2028)
    2.2 Gene Therapy for Ovarian Cancer Growth Trends by Region
        2.2.1 Gene Therapy for Ovarian Cancer Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Gene Therapy for Ovarian Cancer Historic Market Size by Region (2017-2022)
        2.2.3 Gene Therapy for Ovarian Cancer Forecasted Market Size by Region (2023-2028)
    2.3 Gene Therapy for Ovarian Cancer Market Dynamics
        2.3.1 Gene Therapy for Ovarian Cancer Industry Trends
        2.3.2 Gene Therapy for Ovarian Cancer Market Drivers
        2.3.3 Gene Therapy for Ovarian Cancer Market Challenges
        2.3.4 Gene Therapy for Ovarian Cancer Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Gene Therapy for Ovarian Cancer Players by Revenue
        3.1.1 Global Top Gene Therapy for Ovarian Cancer Players by Revenue (2017-2022)
        3.1.2 Global Gene Therapy for Ovarian Cancer Revenue Market Share by Players (2017-2022)
    3.2 Global Gene Therapy for Ovarian Cancer Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Gene Therapy for Ovarian Cancer Revenue
    3.4 Global Gene Therapy for Ovarian Cancer Market Concentration Ratio
        3.4.1 Global Gene Therapy for Ovarian Cancer Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Gene Therapy for Ovarian Cancer Revenue in 2021
    3.5 Gene Therapy for Ovarian Cancer Key Players Head office and Area Served
    3.6 Key Players Gene Therapy for Ovarian Cancer Product Solution and Service
    3.7 Date of Enter into Gene Therapy for Ovarian Cancer Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Gene Therapy for Ovarian Cancer Breakdown Data by Type
    4.1 Global Gene Therapy for Ovarian Cancer Historic Market Size by Type (2017-2022)
    4.2 Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Type (2023-2028)
5 Gene Therapy for Ovarian Cancer Breakdown Data by Application
    5.1 Global Gene Therapy for Ovarian Cancer Historic Market Size by Application (2017-2022)
    5.2 Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Gene Therapy for Ovarian Cancer Market Size (2017-2028)
    6.2 North America Gene Therapy for Ovarian Cancer Market Size by Country (2017-2022)
    6.3 North America Gene Therapy for Ovarian Cancer Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Gene Therapy for Ovarian Cancer Market Size (2017-2028)
    7.2 Europe Gene Therapy for Ovarian Cancer Market Size by Country (2017-2022)
    7.3 Europe Gene Therapy for Ovarian Cancer Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size (2017-2028)
    8.2 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Country (2017-2022)
    8.3 Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Gene Therapy for Ovarian Cancer Market Size (2017-2028)
    9.2 Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2017-2022)
    9.3 Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size (2017-2028)
    10.2 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2017-2022)
    10.3 Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Takara Bio
        11.1.1 Takara Bio Company Detail
        11.1.2 Takara Bio Business Overview
        11.1.3 Takara Bio Gene Therapy for Ovarian Cancer Introduction
        11.1.4 Takara Bio Revenue in Gene Therapy for Ovarian Cancer Business (2017-2022)
        11.1.5 Takara Bio Recent Development
    11.2 VBL Therapeutics
        11.2.1 VBL Therapeutics Company Detail
        11.2.2 VBL Therapeutics Business Overview
        11.2.3 VBL Therapeutics Gene Therapy for Ovarian Cancer Introduction
        11.2.4 VBL Therapeutics Revenue in Gene Therapy for Ovarian Cancer Business (2017-2022)
        11.2.5 VBL Therapeutics Recent Development
    11.3 CELSION
        11.3.1 CELSION Company Detail
        11.3.2 CELSION Business Overview
        11.3.3 CELSION Gene Therapy for Ovarian Cancer Introduction
        11.3.4 CELSION Revenue in Gene Therapy for Ovarian Cancer Business (2017-2022)
        11.3.5 CELSION Recent Development
    11.4 Targovax
        11.4.1 Targovax Company Detail
        11.4.2 Targovax Business Overview
        11.4.3 Targovax Gene Therapy for Ovarian Cancer Introduction
        11.4.4 Targovax Revenue in Gene Therapy for Ovarian Cancer Business (2017-2022)
        11.4.5 Targovax Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Gene Therapy for Ovarian Cancer Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Intravenous
    Table 3. Key Players of Intratumoral
    Table 4. Key Players of Intraperitoneal
    Table 5. Global Gene Therapy for Ovarian Cancer Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 6. Global Gene Therapy for Ovarian Cancer Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 7. Global Gene Therapy for Ovarian Cancer Market Size by Region (2017-2022) & (US$ Million)
    Table 8. Global Gene Therapy for Ovarian Cancer Market Share by Region (2017-2022)
    Table 9. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 10. Global Gene Therapy for Ovarian Cancer Market Share by Region (2023-2028)
    Table 11. Gene Therapy for Ovarian Cancer Market Trends
    Table 12. Gene Therapy for Ovarian Cancer Market Drivers
    Table 13. Gene Therapy for Ovarian Cancer Market Challenges
    Table 14. Gene Therapy for Ovarian Cancer Market Restraints
    Table 15. Global Gene Therapy for Ovarian Cancer Revenue by Players (2017-2022) & (US$ Million)
    Table 16. Global Gene Therapy for Ovarian Cancer Market Share by Players (2017-2022)
    Table 17. Global Top Gene Therapy for Ovarian Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Ovarian Cancer as of 2021)
    Table 18. Ranking of Global Top Gene Therapy for Ovarian Cancer Companies by Revenue (US$ Million) in 2021
    Table 19. Global 5 Largest Players Market Share by Gene Therapy for Ovarian Cancer Revenue (CR5 and HHI) & (2017-2022)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Gene Therapy for Ovarian Cancer Product Solution and Service
    Table 22. Date of Enter into Gene Therapy for Ovarian Cancer Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Gene Therapy for Ovarian Cancer Market Size by Type (2017-2022) & (US$ Million)
    Table 25. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Type (2017-2022)
    Table 26. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 27. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Type (2023-2028)
    Table 28. Global Gene Therapy for Ovarian Cancer Market Size by Application (2017-2022) & (US$ Million)
    Table 29. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Application (2017-2022)
    Table 30. Global Gene Therapy for Ovarian Cancer Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 31. Global Gene Therapy for Ovarian Cancer Revenue Market Share by Application (2023-2028)
    Table 32. North America Gene Therapy for Ovarian Cancer Market Size by Country (2017-2022) & (US$ Million)
    Table 33. North America Gene Therapy for Ovarian Cancer Market Size by Country (2023-2028) & (US$ Million)
    Table 34. Europe Gene Therapy for Ovarian Cancer Market Size by Country (2017-2022) & (US$ Million)
    Table 35. Europe Gene Therapy for Ovarian Cancer Market Size by Country (2023-2028) & (US$ Million)
    Table 36. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Region (2017-2022) & (US$ Million)
    Table 37. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size by Region (2023-2028) & (US$ Million)
    Table 38. Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2017-2022) & (US$ Million)
    Table 39. Latin America Gene Therapy for Ovarian Cancer Market Size by Country (2023-2028) & (US$ Million)
    Table 40. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2017-2022) & (US$ Million)
    Table 41. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size by Country (2023-2028) & (US$ Million)
    Table 42. Takara Bio Company Detail
    Table 43. Takara Bio Business Overview
    Table 44. Takara Bio Gene Therapy for Ovarian Cancer Product
    Table 45. Takara Bio Revenue in Gene Therapy for Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 46. Takara Bio Recent Development
    Table 47. VBL Therapeutics Company Detail
    Table 48. VBL Therapeutics Business Overview
    Table 49. VBL Therapeutics Gene Therapy for Ovarian Cancer Product
    Table 50. VBL Therapeutics Revenue in Gene Therapy for Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 51. VBL Therapeutics Recent Development
    Table 52. CELSION Company Detail
    Table 53. CELSION Business Overview
    Table 54. CELSION Gene Therapy for Ovarian Cancer Product
    Table 55. CELSION Revenue in Gene Therapy for Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 56. CELSION Recent Development
    Table 57. Targovax Company Detail
    Table 58. Targovax Business Overview
    Table 59. Targovax Gene Therapy for Ovarian Cancer Product
    Table 60. Targovax Revenue in Gene Therapy for Ovarian Cancer Business (2017-2022) & (US$ Million)
    Table 61. Targovax Recent Development
    Table 62. Research Programs/Design for This Report
    Table 63. Key Data Information from Secondary Sources
    Table 64. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Gene Therapy for Ovarian Cancer Market Share by Type: 2021 VS 2028
    Figure 2. Intravenous Features
    Figure 3. Intratumoral Features
    Figure 4. Intraperitoneal Features
    Figure 5. Global Gene Therapy for Ovarian Cancer Market Share by Application in 2021 & 2028
    Figure 6. Ovarian Cancer (Unspecified) Case Studies
    Figure 7. Recurrent Ovarian Epithelial Cancer Case Studies
    Figure 8. Platinum-Resistant Ovarian Cancer Case Studies
    Figure 9. Gene Therapy for Ovarian Cancer Report Years Considered
    Figure 10. Global Gene Therapy for Ovarian Cancer Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 11. Global Gene Therapy for Ovarian Cancer Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 12. Global Gene Therapy for Ovarian Cancer Market Share by Region: 2021 VS 2028
    Figure 13. Global Gene Therapy for Ovarian Cancer Market Share by Players in 2021
    Figure 14. Global Top Gene Therapy for Ovarian Cancer Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gene Therapy for Ovarian Cancer as of 2021)
    Figure 15. The Top 10 and 5 Players Market Share by Gene Therapy for Ovarian Cancer Revenue in 2021
    Figure 16. North America Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 17. North America Gene Therapy for Ovarian Cancer Market Share by Country (2017-2028)
    Figure 18. United States Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. Canada Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 20. Europe Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Europe Gene Therapy for Ovarian Cancer Market Share by Country (2017-2028)
    Figure 22. Germany Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. France Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 24. U.K. Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. Italy Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. Russia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Nordic Countries Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Asia-Pacific Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Asia-Pacific Gene Therapy for Ovarian Cancer Market Share by Region (2017-2028)
    Figure 30. China Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Japan Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 32. South Korea Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Southeast Asia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. India Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Australia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. Latin America Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Latin America Gene Therapy for Ovarian Cancer Market Share by Country (2017-2028)
    Figure 38. Mexico Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Brazil Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 40. Middle East & Africa Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Middle East & Africa Gene Therapy for Ovarian Cancer Market Share by Country (2017-2028)
    Figure 42. Turkey Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Saudi Arabia Gene Therapy for Ovarian Cancer Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 44. Takara Bio Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2017-2022)
    Figure 45. VBL Therapeutics Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2017-2022)
    Figure 46. CELSION Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2017-2022)
    Figure 47. Targovax Revenue Growth Rate in Gene Therapy for Ovarian Cancer Business (2017-2022)
    Figure 48. Bottom-up and Top-down Approaches for This Report
    Figure 49. Data Triangulation
    Figure 50. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Takara Bio
VBL Therapeutics
CELSION
Targovax
Frequently Asked Questions
Gene Therapy for Ovarian Cancer report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Gene Therapy for Ovarian Cancer report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Gene Therapy for Ovarian Cancer report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

General Lighting

The research report includes specific segments by region (country), by manufacturers, by Type and ... Read More